Adaptive deep brain stimulation for dynamic gait control in Parkinson’s disease: a randomized feasibility trial
Nature Medicine · 2026-08 · 32 (8) · 2803-2814
DOI: 10.1038/s41591-026-04434-2 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nature Medicine, online erschienen am 15.06.2026. Verfasst von Kenneth H Louie und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurological Surgery, University California, San Francisco, San Francisco, CA, USA. Hauptthemen laut MEDLINE: Parkinson Disease, Deep Brain Stimulation, Gait. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS), Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation).
Abstract (Originalsprache)
A randomized crossover study of five patients with Parkinson’s disease (PD) demonstrates that gait-synchronized adaptive deep brain stimulation is feasible and safe, and reduces falls compared with continuous stimulation. Gait dysfunction in PD is a major source of disability and is often insufficiently treated by continuous deep brain stimulation (cDBS). Although adaptive DBS (aDBS) has shown efficacy for other motor symptoms using β-based, state-driven neural signals, gait is a dynamic, cyclical behavior that may require temporally precise modulation. Here we evaluated a behavior-contingent aDBS approach that synchronizes stimulation to gait phase. We reported a single-center, blinded, randomized, crossover study evaluating the feasibility of identifying patient-specific biomarkers to drive aDBS. The primary outcome was feasibility of successful identification of gait-phase biomarkers to implement aDBS. Five participants with PD undergoing pallidal DBS and subdural electrode paddle implantation were enrolled. We successfully identified personalized gait-phase biomarkers from cortical or pallidal field potentials in all five patients and embedded them into a bidirectional neurostimulator. During acute in-clinic testing, aDBS improved step variability and step symmetry versus cDBS. Three participants subsequently completed a double-blinded, multi-day crossover phase. In this setting, aDBS maintained general motor symptom control, reduced falls and yielded patient-specific gait improvements. No adverse events occurred and aDBS was well tolerated. These findings establish the feasibility of biomarker-driven, movement-synchronized neuromodulation and support the development of a larger randomized trial to determine clinical efficacy. ClinicalTrial.gov registration: NCT04675398 .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurological Surgery, University California, San Francisco, San Francisco, CA, USA.
- Department of Physical Therapy and Rehabilitation Sciences, University of California, San Francisco, San Francisco, CA, USA.
- Department of Applied Physiology & Kinesiology, University of Florida, Gainesville, FL, USA.
- Graduate Program in Bioengineering, University of California, Berkeley and University of California, San Francisco, San Francisco, CA, USA.
- Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.
- Department of Neurological Surgery, University California, San Francisco, San Francisco, CA, USA. doris.wang@ucsf.edu.
Förderung
- NINDS NIH HHS
- U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS)
- Michael J. Fox Foundation for Parkinson's Research (Michael J. Fox Foundation)
- Michael J. Fox Foundation for Parkinson’s Research
- UCSF Burroughs Wellcome Fund Career Award for Medical Scientist; UCSF Catalyst Grants
Zitieren
APA
Louie, K. H., Balakid, J. P., Bath, J. E., Song, S., Fekri Azgomi, H., Marks, J. H., Choi, J. T., Starr, P. A., & Wang, D. D. (2026). Adaptive deep brain stimulation for dynamic gait control in Parkinson’s disease: a randomized feasibility trial. Nature Medicine, 32(8), 2803-2814. https://doi.org/10.1038/s41591-026-04434-2
Vancouver
Louie KH, Balakid JP, Bath JE, Song S, Fekri Azgomi H, Marks JH, et al. Adaptive deep brain stimulation for dynamic gait control in Parkinson’s disease: a randomized feasibility trial. Nature Medicine. 2026;32(8):2803-2814. doi:10.1038/s41591-026-04434-2
BibTeX
@article{Louie2026,
author = {Louie, Kenneth H and Balakid, Jannine P and Bath, Jessica E and Song, Seongmi and Fekri Azgomi, Hamid and Marks, Jacob H and Choi, Julia T and Starr, Philip A and Wang, Doris D},
title = {Adaptive deep brain stimulation for dynamic gait control in Parkinson’s disease: a randomized feasibility trial},
journal = {Nature Medicine},
year = {2026},
volume = {32},
number = {8},
pages = {2803--2814},
doi = {10.1038/s41591-026-04434-2}
}
EUVIMED